Inivata appoint Dr Peter Brighton-Smith to its Board of Directors
– UK, Cambridge – Inivata, a global clinical cancer genomics company employing the precision of circulating tumour DNA (ctDNA) analysis to improve personalised healthcare in oncology, has appointed Dr Peter Wrighton-Smith to its Board of Directors.…